Prof . Lumír Ondřej Hanuš
A world-renowned analytical chemist and a leading figure in the field of cannabis research, who is responsible for groundbreaking research in the world of cannabinoids. His award-winning research serves as the basis for much of what we know about the plant today. In 1992, Prof. Hanuš isolated the first known endocannabinoid in the human brain, Anandamide, named after the Sanskrit word for bliss. The discovery confirmed that the human brain produces ”cannabinoids ” of its own, called endocannabinoids, which bind with cannabinoid receptors throughout the brain and body.
Dr. Sari Prutchi Sagiv
Dr. Prutchi Sagiv has over 15 years of experience in various aspects of pharmaceutical development including: discovery, regulatory affairs, intellectual property, business development, clinical trials, and marketing. Dr. Prutchi Sagiv has lead the Scientific Operations in multiple cannabis-based drugs companies including Talent Biotech and BOL Pharma. She serves as Director of Tech Transfer at Mor Research Applications (Clalit Health Services commercializing arm), where she is responsible for raising capital via strategic partnerships for early stage technologies.
Eran is VP Business Development at Dr. Golik Scientific Solutions, the leader in the field of chemical and scientific instrumentations in Israel. The company specializes in professional, high quality scientific solutions in a variety of areas such as analytical and organic chemistry, physical characterization of particles and materials, biochemistry and many additional fields.
Owner of Livni Hydroponics, Gilad is a master grower experienced in production of medical cannabis supplied to patients, hospitals and clinical trials throughout Israel since 2008. Gilad has been a genetic development consultant for numerous cannabis producers and biotech companies both in Israel and abroad.